Cargando…

Clinical outcome of patients with refractory Kawasaki disease based on treatment modalities

PURPOSE: Although a significant number of reports on new therapeutic options for refractory Kawasaki disease (KD) such as steroid, infliximab, or repeated intravenous immunoglobulin (IVIG) are available, their effectiveness in reducing the prevalence of coronary artery lesions (CAL) remains controve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Hyun Jung, Lee, Hyo Eun, Yu, Jae Won, Kil, Hong Ryang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Pediatric Society 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5014912/ https://www.ncbi.nlm.nih.gov/pubmed/27610181 http://dx.doi.org/10.3345/kjp.2016.59.8.328

Ejemplares similares

Clinical outcome of acute myocarditis in children according to treatment modalities
por: Kim, Hyun Jung, et al.
Publicado: (2010)

The outcome of short-term low-dose aspirin treatment in Kawasaki disease based on inflammatory markers
por: Yoo, Jae Won, et al.
Publicado: (2017)

Association between Adipokines and Coronary Artery Lesions in Children with Kawasaki Disease
por: Kim, Hyun Jung, et al.
Publicado: (2014)

Elevated Plasma Apurinic/Apyrimidinic Endonuclease 1/Redox Effector Factor-1 Levels in Refractory Kawasaki Disease
por: Lee, Yu-Ran, et al.
Publicado: (2022)

Kawasaki Disease and Hyponatremia
por: Kil, Hong Ryang
Publicado: (2010)

Changes in clinical and laboratory features of Kawasaki disease noted over time in Daejeon, Korea
por: Kil, Hong-Ryang, et al.
Publicado: (2017)

Clinical implications in laboratory parameter values in acute Kawasaki disease for early diagnosis and proper treatment
por: Seo, Yu-Mi, et al.
Publicado: (2018)

The Usefulness of Platelet-derived Microparticle as Biomarker of Antiplatelet Therapy in Kawasaki Disease
por: Kim, Hyun Jung, et al.
Publicado: (2017)

Changes of clinical characteristics and outcomes in patients with Kawasaki disease over the past 7 years in a single center study
por: Kang, Hye Jin, et al.
Publicado: (2013)

Prediction of unresponsiveness to second intravenous immunoglobulin treatment in patients with Kawasaki disease refractory to initial treatment
por: Seo, Euri, et al.
Publicado: (2016)

Predicting Factors for Refractory Kawasaki Disease
por: Do, Young-Sun, et al.
Publicado: (2010)

Cardiovascular risk factors of early atherosclerosis in school-aged children after Kawasaki disease
por: Cho, Hyun Jeong, et al.
Publicado: (2014)

Infliximab Treatment for Refractory Kawasaki Disease in Korean Children
por: Song, Min Seob, et al.
Publicado: (2010)

IgA Levels Are Associated with Coronary Artery Lesions in Kawasaki Disease
por: Kim, Jae-Jung, et al.
Publicado: (2021)

Recurrent refractory Kawasaki disease
por: Costa Reis, P, et al.
Publicado: (2011)

Assessment of the Clinical Heterogeneity of Kawasaki Disease Using Genetic Variants of BLK and FCGR2A
por: Sim, Bo Kyung, et al.
Publicado: (2018)

Effects of Methylprednisolone Pulse Therapy on Refractory Mycoplasma pneumoniae Pneumonia in Children
por: You, Sun Young, et al.
Publicado: (2014)

Identification of rare coding variants associated with Kawasaki disease by whole exome sequencing
por: Kim, Jae-Jung, et al.
Publicado: (2021)

Hepatobiliary risk factors for clinical outcome of Kawasaki disease in children
por: Yi, Dae Yong, et al.
Publicado: (2014)

Clinical Outcomes Associated with Treatment Modalities for Gastrointestinal Bezoars
por: Park, So-Eun, et al.
Publicado: (2014)

Usefulness of anterior uveitis as an additional tool for diagnosing incomplete Kawasaki disease
por: Lee, Kyu Jin, et al.
Publicado: (2016)

Consortium-Based Genetic Studies of Kawasaki Disease in Korea: Korean Kawasaki Disease Genetics Consortium
por: Lee, Jong-Keuk, et al.
Publicado: (2015)

Production of Chemokines in Kawasaki Disease, Henoch-Schönlein Purpura and Acute Febrile Illness
por: Chung, Hyo Seok, et al.
Publicado: (2004)

Infliximab as rescue therapy in refractory Kawasaki disease
por: Rodríguez-González, Moisés, et al.
Publicado: (2014)

Refractory Kawasaki disease: diagnostic and management challenges
por: Duignan, Sophie, et al.
Publicado: (2019)

Cyclosporine for refractory Kawasaki disease with psoriasiform eruption
por: Leyendecker, Mara, et al.
Publicado: (2021)

Refractory Kawasaki Disease—a Challenge for the Pediatrician
por: Abraham, Deepu, et al.
Publicado: (2021)

Predictors of nonresponse to intravenous immunoglobulin therapy in Kawasaki disease
por: Park, Hyo Min, et al.
Publicado: (2013)

Risk factors for refractory Kawasaki disease: clinical records of the paediatric clinic of palermo
por: Maggio, Maria Cristina, et al.
Publicado: (2014)

Cyclophosphamide use in treatment of refractory Kawasaki disease with coronary artery aneurysms
por: Halyabar, Olha, et al.
Publicado: (2021)

Male-specific association of the FCGR2A His167Arg polymorphism with Kawasaki disease
por: Kwon, Young-Chang, et al.
Publicado: (2017)

Clinical characteristics of hemophagocytic lymphohistiocytosis following Kawasaki disease: differentiation from recurrent Kawasaki disease
por: Kang, Hae-Ryong, et al.
Publicado: (2013)

Kawasaki disease in infants
por: Yeom, Jung Sook, et al.
Publicado: (2013)

Indirect-comparison meta-analysis of treatment options for patients with refractory Kawasaki disease
por: Chan, Han, et al.
Publicado: (2019)

Clinical Outcomes of Initial Dexamethasone Treatment Combined with a Single High Dose of Intravenous Immunoglobulin for Primary Treatment of Kawasaki Disease
por: Lim, Yun Ju, et al.
Publicado: (2014)

Under-Recognized Macrophage Activation Syndrome in Refractory Kawasaki Disease: A Wolf in Sheep’s Clothing
por: Rhee, Sangwon, et al.
Publicado: (2022)

Epidemiology of Kawasaki disease in infants 3 months of age and younger
por: Lee, Eun Jung, et al.
Publicado: (2012)

Diagnostic characteristics of supplemental laboratory criteria for incomplete Kawasaki disease in children with complete Kawasaki disease
por: Jun, Hyun Ok, et al.
Publicado: (2015)

Differentiation between incomplete Kawasaki disease and secondary hemophagocytic lymphohistiocytosis following Kawasaki disease using N-terminal pro-brain natriuretic peptide
por: Choi, Jung Eun, et al.
Publicado: (2018)

Long Term Outcomes of Left Atrial Reservoir Function in Children with a History of Kawasaki Disease
por: Kang, Soo Jung, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_7hjsdhuqg35g7pk1u8u74dlfta